An increase in the level of IL-33 synthesized in the endothelium and EAT thickness may be indicative of the pathogenic processes associated with CVD, namely endothelial dysfunction and lipid metabolism disorders. This evidence concerns the gene IL33 and Disorder of lipid metabolism.